Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay

Journal of Pathology

Volumn 221, Issue 4, 2010, Pages 452-461

  Waddell, Nic ^a,b   Cocciardi, Sibylle ^a   Johnson, Julie ^a   Healey, Sue ^a   Marsh, Anna ^a   Riley, Joan ^c   Da Silva, Leonard ^d   Vargas, Ana Cristina ^d   Reid, Lynne ^d   Simpson, Peter T ^d   Lakhani, Sunil R ^d   Chenevix Trench, Georgia ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ATM; BRCA1 and BRCA2; Familial breast cancer; Formalin fixed; Gene expression; Molecular subtypes; Paraffin embedded tissue; Whole genome DASL

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; COMPLEMENTARY DNA; FORMALDEHYDE; PARAFFIN;

ARTICLE; BREAST CANCER; CDNA MEDIATED ANNEALING SELECTION EXTENSION LIGATION ASSAY; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; RNA DEGRADATION; RNA EXTRACTION;

BREAST NEOPLASMS; CELL CYCLE PROTEINS; CRYOPRESERVATION; DNA-BINDING PROTEINS; FEMALE; FORMALDEHYDE; GENE EXPRESSION PROFILING; GENES, BRCA1; GENES, BRCA2; GENOME; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; PROTEIN-SERINE-THREONINE KINASES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEINS;

EID: 77955491622     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2728     Document Type: Article

References (27)

1. Bibikova M, Talantov D, Chudin E, et al . Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 2004; 165: 1799-1807. (Pubitemid 39435177)
2. Bibikova M, Yeakley JM, Wang-Rodriguez J, et al . Quantitative expression profiling of RNA from formalin-fixed, paraffin-embedded tissues using randomly assembled bead arrays. Methods Mol Biol 2008; 439: 159-177.
3. Fan JB, Yeakley JM, Bibikova M, et al . A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 2004; 14: 878-885.
4. Duenwald S, Zhou M, Wang Y, et al . Development of a microarray platform for FFPET profiling: application to the classification of human tumors. J Transl Med 2009; 7: 65.
5. Conway C, Mitra A, Jewell R, et al . Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin Cancer Res 2009; 15: 6939-6946.
6. Abramovitz M, Ordanic-Kodani M, Wang Y, et al . Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. Biotechniques 2008; 44: 417-423.
7. Da Silva L, Parry S, Reid L, et al . Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 2008; 32: 773-783.
8. Di Cesare S, Nantel A, Marshall JC, et al . Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices. J Cancer Res Clin Oncol 2010; 136: 577-586.
9. Haller AC, Kanakapalli D, Walter R, et al . Transcriptional profiling of degraded RNA in cryopreserved and fixed tissue samples obtained at autopsy. BMC Clin Pathol 2006; 6: 9.
10. Ravo M, Mutarelli M, Ferraro L, et al . Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. Lab Invest 2008; 88: 430-440. (Pubitemid 351432771)
11. April C, Klotzle B, Royce T, et al . Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS One 2009; 4: e8162.
12. Chien J, Fan JB, Bell DA, et al . Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol Oncol 2009; 114: 3-11.
13. Perou CM, Jeffrey SS, van de Rijn M, et al . Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 1999; 96: 9212-9217.
14. Hu Z, Fan C, Oh DS, et al . The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006; 7: 96.
15. Perou CM, Sorlie T, Eisen MB, et al . Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
16. Sorlie T, Perou CM, Tibshirani R, et al . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874.
17. Sorlie T, Tibshirani R, Parker J, et al . Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003; 100: 8418-8423.
18. Sotiriou C, Neo SY, McShane LM, et al . Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003; 100: 10393-10398.
19. van 't Veer LJ, Dai H, van de Vijver MJ, et al . Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.
20. Fong PC, Boss DS, Yap TA, et al . Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009; 361: 123-134.
21. Waddell N, Arnold J, Cocciardi S, et al . Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res Treat 2009; [Epub ahead of print].
22. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548. (Pubitemid 351911712)
23. Benito M, Parker J, Du Q, et al . Adjustment of systematic microarray data biases. Bioinformatics 2004; 20: 105-114.
24. Kuhn K, Baker SC, Chudin E, et al . A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res 2004; 14: 2347-2356.
25. Mecham BH, Klus GT, Strovel J, et al . Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. Nucleic Acids Res 2004; 32: e74.
26. Tavtigian SV, Oefner PJ, Babikyan D, et al . Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet 2009; 85: 427-446.
27. Honrado E, OsorioA, MilneRL, et al . Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod Pathol 2007; 20: 1298-1306.